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Retinoic acid (RA) has been identified as a key signal involved in the posteriorization of vertebrate neural ectoderm. The main
biosynthetic enzyme responsible for RA signaling in the hindbrain and spinal cord is Raldh2. However, neckless/raldh2-mutant (nls)
zebrafish exhibit only mild degrees of anteriorization in the neural ectoderm, compared to full vitamin A deficiency in amniotes and the
Raldh2/ mouse. Here we investigated the role of RA during neuronal development in the zebrafish hindbrain and anterior spinal cord using
DEAB, an inhibitor of retinaldehyde dehydrogenases. We show that the nls hindbrain and spinal cord are not fully devoid of RA, since
blocking Raldh-mediated RA signaling leads to a more severe hindbrain phenotype than in nls. The anteroposterior distribution of
branchiomotor neurons in the facial and more posterior nuclei depends on full RA signaling throughout early and late gastrula stages. In
contrast, inhibition of RA synthesis after gastrulation reduces the number of branchiomotor neurons in the vagal nucleus, but has no effect on
anteroposterior cell fates. In addition, blockage of RA-mediated signaling not only interferes with the differentiation of branchiomotor
neurons and their axons in the hindbrain, but also affects the development of the posterior lateral line nerve.
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Introduction RA is synthesized from dietary sources of vitamin A,Retinoic acid (RA) is a morphogenetically active signal-
ing molecule with important roles in various developmental
processes in vertebrates (Eichele, 1997; Morriss-Kay and
Ward, 1999). The developing central nervous system (CNS)
is particularly sensitive to variation in the amounts of
retinoid signaling (Maden, 2002). Ectopic application of
retinoic acid causes patterning defects in the hindbrain and
anterior spinal cord by transforming anterior neural tissue
toward a more posterior neural specification (posterioriza-
tion) (Durston et al., 1989). Excess retinoid signaling does
not influence early neural induction, but it represses fore-
brain- and midbrain-specific gene expression domains with-
in already induced neural tissue, while posterior markers are
expanded anteriorly (Gavalas and Krumlauf, 2000).0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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und Tierphysiologie, Erbertstrasse 1, 07743 Jena, Germany.through the oxidation to retinaldehyde by alcohol dehydro-
genases and the subsequent conversion to RA by retinalde-
hyde dehydrogenases. In the amniote embryo, three enzymes,
Raldh1 (Aldh1a1), Raldh2 (Aldh1a2) and Raldh3 (Aldh1a3),
are capable of synthesizing RA. However, only Raldh2
appears to participate in the early posteriorization process
of the neural tube (Niederreither et al., 2002). The effects of
reduced RA signaling are mimicked by depleting the devel-
oping embryo of dietary sources of vitamin A. The ensuing
developmental defects include the anteriorization of the
hindbrain and are collectively known as vitaminA-deficiency
(VAD) syndrome (Dickman et al., 1997; Maden et al., 1996;
Morriss-Kay and Sokolova, 1996). During normal develop-
ment, the vertebrate hindbrain transiently forms distinct seg-
ments called rhombomeres (r). Each rhombomere has an
individual identity as exemplified by gene expression pat-
terns and contains neurons with rhombomere-specific axon
navigation behavior and neural crest cells with specific
migration routes. In amniote VAD embryos, the caudal
hindbrain is transformed toward more anterior fates, resulting
in enlarged anterior rhombomeres and a truncation of rhom-
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increasing concentrations of RA to VAD rat embryos, a
gradual rescue of caudal rhombomeric gene expression can
be achieved (Gale et al., 1999; Maden et al., 1996).
Mutations in the zebrafish retinaldehyde dehydrogenase
2 (raldh2) gene, raldh2/neckless (nls), have been described
and recapitulate some of the phenotypes that are typical of
VAD in vertebrate embryos. Both studied alleles (nlsi26 and
nlsno fin) exhibit defects in patterning of the caudal-most
hindbrain and the spinal cord (Begemann et al., 2001;
Grandel et al., 2002). The neural patterning defects are
comparable to milder forms of VAD in rat embryos (White
et al., 2000) and to the partial rescue of Raldh2/ mice by
maternal application of RA (Niederreither et al., 2000),
rather than to complete elimination of RA signaling.
In contrast, the gene knockout of Raldh2 in the mouse
mimics the hindbrain phenotypes associated with full VAD
(Niederreither et al., 1999, 2000) and establishes Raldh2 as
the main RA-producing enzyme required in the hindbrain
during amniote embryonic development (Berggren et al.,
1999; Niederreither et al., 1997). It is unlikely that nls is a
hypomorphic mutation, since the non-neural developmental
defects, in the nls branchial arch skeleton and pectoral fins,
are stronger or as strong as in full VAD and Raldh2/mice,
and morpholino-mediated knockdown of raldh2 leads to
exact phenocopies of nls (Begemann et al., 2001; Grandel et
al., 2002). This raises the possibility that zebrafish may
possess an additional retinaldehyde dehydrogenase, either a
paralogous raldh2 gene or another member of the Raldh-
protein subfamily, that can partially compensate for the loss
of RA signaling during neural patterning.
The effects of RA on patterning the neural plate have
been widely studied. However, little is known about how
RA signaling affects neuronal patterning and differentiation.
Here we have investigated the role of RA during neuronal
development in the hindbrain and anterior spinal cord using
an inhibitor of retinaldehyde dehydrogenases and have
characterized neuronal patterning in both nls and RA
signaling-inhibited embryos. We asked the question, how
is the differentiation and axonal projection pattern of neu-
ronal subtypes in the hindbrain altered in RA-depleted fish?
We show that the nls hindbrain and spinal cord are not fully
devoid of RA, as blocking Raldh-mediated RA signaling
leads to a more severe hindbrain phenotype than in nls.
Inhibition of RA signaling not only interferes with the
differentiation of branchiomotor neurons and their axons
in the hindbrain but also affects the development of the
posterior lateral line nerve.Material and methods
Zebrafish husbandry
London wild type and WIK strains of zebrafish were
reared and staged at 28.5jC according to Kimmel et al.(1995). The mutant phenotypes of both raldh2 alleles, nlsi26
(Begemann et al., 2001) and nlsno fin (Grandel et al., 2002),
cannot be distinguished from each other, and experiments
were performed with both alleles. Transgenic zebrafish
expressing GFP under the control of the islet-1 gene
regulatory elements were kindly provided by S.I. Higashi-
jima (Higashijima et al., 2000).
In situ hybridisation
Whole mount in situ hybridisation was performed as
previously described (Begemann et al., 2001), using the
following probes: hoxb4a (Prince et al., 1998), isl-1 (Inoue
et al., 1994), krox-20 (egr2b; www.zfin.org) (Oxtoby and
Jowett, 1993), pax2a (Krauss et al., 1992), raldh2 (Bege-
mann et al., 2001), val (Moens et al., 1998).
Retinoic acid and DEAB treatments
Batches of embryos from wild type or nls heterozygous
parents were incubated in the dark from late blastula stage
onwards in varying dilutions (in embryo medium) of a 104
M all-trans RA (Sigma)/10% ethanol solution (from a 102
M stock solution in DMSO). DEAB (4-diethylaminoben-
zaldehyde; Fluka) was applied in the dark, in concentrations
of 105 M and 2  105 M in embryo medium from a 102
M stock in DMSO. BMS493 was diluted to 105 and 106
M from a 102 M stock solution in ethanol. As controls,
sibling embryos were treated with equivalent concentrations
of ethanol/DMSO or DMSO alone.
Antibody staining and analysis
Zebrafish embryos were processed for whole-mount
immunohistochemistry as previously described (Weiland et
al., 1997). Briefly, embryos were fixed for 4 h at 4jC in 4%
paraformaldehyde in 1 fixation buffer (Westerfield, 1995)
and permeabilized by exposure to acetone (20jC for 2–3
min). After incubation in blocking buffer (PBS with 1%
BSA, 1% DMSO) for 1 h at 37jC, they were exposed to
primary antibodies overnight at 4jC. To visualize zebrafish
axons the following antibodies were used: a monoclonal
antibody against zebrafish L1 (zL1, Mab E17, 25 Ag/ml;
Weiland et al., 1997), a monoclonal IgG-antibody against
the polysialated form of NCAM (PSA, Mab 735, 25 Ag/ml;
kindly provided by R. Gerardy-Schahn), a monoclonal IgM-
antibody against PSA (Mab 12E3, 20 Ag/ml; Marx et al.,
2001), and a polyclonal serum against zebrafish TAG-1
(zTAG-1; Lang et al., 2001; Ott et al., 2001). Embryos were
rinsed in blocking buffer and incubated with the following
secondary antibodies: Alexa-488-coupled goat anti-rabbit (2
Ag/ml; Molecular Probes), Alexa-488-coupled goat anti-
mouse (2 Ag/ml; Molecular Probes), cyanin-3-coupled don-
key anti-mouse IgG (H+L) (2 Ag/ml; Dianova), or cyanin-3-
coupled goat anti-mouse IgM, A-chain specific (2 Ag/ml,
Dianova), for 2 h at 37jC. For microscopy, yolk sacs were
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ing n-propylgallate as an antifading agent) between two
coverslips. GFP-fluorescence was assayed immediately fol-
lowing fixation. Stained embryos were analyzed with a
confocal microscope (LSM 510, Zeiss, Jena, Germany)
equipped with high aperture lenses and the appropriate
lasers. Serial optical sections were flattened into projections.
All images were further processed with Adobe Photoshop
6.0 software.Results
Inhibitors of RA signaling phenocopy nls/raldh2 to various
amounts
Compared to the inactivation of Raldh2 in the mouse,
nls/raldh2 mutant embryos resemble a state of intermediate
vitamin A deficiency (Begemann et al., 2001; Grandel et al.,
2002). However, the effects of targeted knockdown of
raldh2 mRNA and the molecular nature of both alleles of
raldh2 in zebrafish suggests that they are complete loss-of-
function mutations. Therefore, it is conceivable that nls
mutants retain low levels of RA activity, which may be
provided maternally or from a yet unidentified enzymatic
activity other than nls/raldh2. To test this possibility, zebra-
fish embryos were treated with two different chemicals
which interfere with RA signaling. We used either
BMS493, a pan-retinoic acid receptor antagonist, or dieth-Fig. 1. Developmental defects in live embryos at 40 hpf when retinoic acid signali
between otic vesicle (arrowhead) and first somite (asterisk); the pectoral fin b
characteristically foreshortened, the distance between otic vesicle and first somit
signaling with the pan-RA receptor antagonist BMS493 exhibits very similar ph
DEAB from 50% epiboly onwards display a nls-like phenotype; the distance betwe
missing. Lateral views; anterior to the left. Scale bar, 500 Am.ylaminobenzaldehyde (DEAB), a competitive, reversible
inhibitor of retinaldehyde dehydrogenases (Perz-Edwards
et al., 2001; Russo et al., 1988).
Wild type embryos were treated with BMS493 or DEAB
starting at 5-h post-fertilization (hpf) and investigated at 40
hpf. At the morphological level, embryos treated with either
inhibitor exhibit most of the developmental defects specific
to nls embryos. These include a reduction of head meso-
derm along the anteroposterior (AP) axis, resulting in close
apposition of otic vesicle and trunk somites, and a shorten-
ing of the hindbrain, resulting in a pronounced kink at the
hindbrain–spinal cord junction (Figs. 1A–D). Furthermore,
like in nls mutants, pectoral fin buds fail to form and cardiac
edema develop after 48 hpf (not shown).
We next assayed segmental patterning in the hindbrain.
In the wild type, krox-20 is expressed in a segment-
specific pattern in r3 and r5, while hoxb4a is expressed
in r7 and extends posteriorly in the spinal cord (Fig. 2A).
In nls, expression of krox-20 in both rhombomeres is
slightly expanded and expression of hoxb4a is present at
20 h post fertilization (hpf), suggesting that rhombomeres
are mildly posteriorized (Fig. 2B). When treated with 105
M BMS493, rhombomeric gene expression is similar to
and not significantly more severe than nls (Fig. 2C)
(Grandel et al., 2002). When treated with DEAB, expres-
sion of krox-20 is greatly reduced in r5 and remains only
in its anterior most part; the concomitant loss of hoxb4a
expression suggests that rhombomere boundaries posterior
to r5 do not form (Fig. 2D). As expected, application ofng is impaired. (A) Wild type embryos are characterized by a large distance
uds are well developed (arrow). (B) In nls mutant embryos, the head is
e is reduced, and pectoral fin buds fail to develop. (C) Inactivation of RA
enotypes in the hindbrain and pectoral fin buds. (D) Embryos exposed to
en otic vesicle and first somite is dramatically reduced; pectoral fin buds are
Fig. 2. Hindbrain patterning defects in response to alterations in retinoic acid signaling. Expression of krox-20 in rhombomeres (r) 3 and r5, and hoxb4a in the
neural tube, posterior to the r6/r7 boundary, in 20 hpf wild type embryos (A); posterior expansion of r3-5 in nls mutant embryos, hoxb4a expression is present,
but often weaker (B); 10 AM of the pan-RAR antagonist BMS493 phenocopies posterior expansion of r3-5 rhombomere boundaries in nls; hoxb4a expression
is present, but extends less posteriorly than in wt or nls (not shown) (C). Five-micromolar DEAB anteriorizes the hindbrain further than observed in nls or
BMS493-treated embryos (note expansion of r3 and r4), markers of pre-rhombomeric fates posterior to the r4/r5 boundary are reduced (arrows) (D); treatment
with 10 nM RA results in variable levels of posteriorization, as indicated by the reduction of r3; at higher doses (not shown), r3 expression is undetectable (E);
simultaneous treatment with 10 nM RA and 5 AM DEAB rescues normal hindbrain development, and restores hoxb4a expression in the spinal cord (F).
Expression of pax2a delineates the increase in distance (indicated by bracket of identical length in G, H) between the midbrain–hindbrain boundary (mhb) and
the otic vesicle (ov) in wt (G) and nls (H) embryos at 20 hpf; in DEAB-treated embryos (I) expression in the otic vesicles is reduced, sometimes to complete
absence, while the mhb appears unaffected. Arrowheads denote visible rhombomere boundaries. Abbreviations: os: optic stalk, sc: spinal cord; dorsal (A–F)
and lateral (G– I) views, anterior to the left.
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greatly reducing r3 and expanding r5 anteriorly (Fig. 2E)
(Hill et al., 1995; Holder and Hill, 1991). Most impor-
tantly, the patterning defects in DEAB-treated embryos can
be rescued through simultaneous application of RA to
revert to an almost wild type appearance (Fig. 2F),
suggesting that the anteriorizing effect of DEAB can be
attributed to a reduction in RA signaling.
To compare the AP-extension of the hindbrain anterior to
r3, we used the expression of pax2a, a marker for the ventral
diencephalon, the midbrain–hindbrain boundary (mhb), and
the otic placode, as well as valentino (val) to mark r5 and r6
(Fig. 2G). In nls, the mhb is located slightly more posterior
than in wild type; similarly, the otic vesicles are shifted
posteriorly, probably due to the caudal expansion of r5 fates,
as witnessed by a small widening of val expression in the
AP direction (Fig. 2H). As in nls, DEAB-treated embryos
also exhibit a small shift of the mhb posteriorly, whileexpression of pax2a in the otic vesicle is variably reduced
(Fig. 2I).
These results suggest that the teratogenic effects of
DEAB in the developing neural tube are due to inhibition
of retinaldehyde dehydrogenase-mediated RA synthesis.
The phenotypes are comparable to the inactivation of
RALDH2 in amniotes and reveal a state of RA deficiency
in the zebrafish beyond that observed in nls.
Development of cranial motor neurons in the absence of RA
Each hindbrain rhombomere is unique and characterized
by differences in size, number, and projection patterns of
specific neuronal populations. To analyze the effects of
reduced RA signaling on the differentiation of branchiomo-
tor neurons in the hindbrain, we used a transgenic line
expressing green fluorescent protein (GFP) under the con-
trol of the islet-1 (isl-1) promoter (Higashijima et al., 2000).
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hindbrain and spinal cord can be visualized throughout
development (Fig. 3A). To relate changes in the anteropos-
terior positions of branchiomotor nuclei nVII–nX to earlier
patterning defects, we measured their location in relation to
the trigeminal nucleus (nVa), whose position was invariable
with respect to the eyes in these experiments. Embryos were
treated continuously up to 39 hpf with two concentrations of
inhibitor, commencing at varying time points of embryonic
development.
Inhibition of RA signaling between 11 and 39 hpf (prim-
28; (Kimmel et al., 1995) does not influence the anteropos-
terior position of branchiomotor neurons (Figs. 3B, E). In all
cases, we neither observed a reduction in the AP extent of
the vagal (nX) field, nor were developmental or patterning
defects apparent in more anterior regions. However, we
consistently observed a reduction in the number of bran-
chiomotor neurons in the vagal nucleus (nX) to approxi-
mately 25–50% of the numbers found in wild type embryos.
These data suggest, that after the onset of somitogenesis, RA
influences neurogenesis or differentiation of the vagal motorFig. 3. Morphological changes in cranial motor neurons upon RA signaling inhibiti
in a wild type embryo. Brackets mark division into three anteroposterior areas, co
vagal nuclei (X; area III). (B–D) Inhibitor treatment (20 AM DEAB) commencing
anteroposterior areas of the hindbrain; (B) the numbers of vagal nuclei are stro
somitogenesis (11 hpf); the posterior extent of the vagal area is unaffected; (C) t
posterior extent and number; facial nuclei are clearly separated; (D) when inhibition
in number and develop near, such that the border between these cell types canno
commencing at 11 hpf (E), 8 hpf (F), 6 hpf (G), and 1.5 hpf (H) results in comparab
does not exacerbate either the anteroposterior patterning defects nor reductions
alterations to branchiomotor neuron patterning upon RA signaling inhibition (ba
individual sectors is compared to untreated embryos and indicated as percent (%
anterior is to the left. Scale bar: 100 Am.nerves, whereas AP patterning of the motor region is not
affected by DEAB treatments after gastrulation.
When RA signaling was inhibited starting during mid-
gastrulation, from 8 hpf (75% epiboly) onwards, the AP
extent of branchiomotor neurons in the vagal lobes is
reduced in comparison with the wild type, as is the number
of neurons in branchiomotor nuclei (Figs. 3C, F). No
aberrant neural development anterior to nX was observed.
DEAB treatment from 6 hpf (shield stage) onwards reduces
the number of GFP-positive cell bodies in the vagal nucleus
(nX), both at 28 hpf (not shown) and 39 hpf (Figs. 3D, G).
In addition, the AP extent of the vagal (nX) nucleus is
considerably reduced (Figs. 3D, G). The more anteriorly
positioned branchiomotor nucleus of the facial nerve (nVII)
also develops aberrantly. No defects in development of
branchiomotor neurons were evident anterior to nVII. The
nucleus of the glossopharyngeal nerve (IX), situated be-
tween nVII and nX, consists only of a few GFP-positive
neurons and therefore could not be assayed in this study. We
conclude that the number of branchiomotor neurons in the
vagal nucleus, as well as the anteroposterior distribution ofon. (A) Dorsal view of cranial motor neurons expressing Isl1-GFP at 39 hpf
mprising trigeminal branchiomotor (Va, Vp; area I), facial (VII; area II) and
at 11 hpf (B), 8 hpf (C) and 6 hpf (D) results in increased shortening of all
ngly reduced, when inhibition of RA signaling commences during early
reatment at mid-gastrulation (8 hpf onwards) reduces vagal nuclei in both
commences at shield stage (6 hpf), both facial and vagal nuclei are reduced
t be distinguished accurately by position. (E–H) 10 AM DEAB treatment
le reductions; exposure to 10 AMDEAB from the 16-cell stage onwards (H)
in cell number observed in (D) and (G). (I) Graphical representation of
sed on 20 embryos each; Table 1); the average anteroposterior length of
); grey bars indicate 10 AM DEAB concentration. (A–H) Dorsal views,
Fig. 4. islet-1 expression pattern in cranial motor neurons upon RA
signaling inhibition. (A–D) Dorsal views of islet-1 expression in 39 hpf
embryos. (A) In wild type, islet-1 mRNA is expressed in trigeminal (V),
facial (VII), glossopharyngeal (IX) and vagal (X) motor neurons, and in
Rohon-Beard neurons (rb) in the spinal cord. (B) islet-1 expression in wild
type embryos treated with 10 AM DEAB from 11 to 39 hpf. (C) islet-1
expression in nls embryos. (D) islet-1 expression in wild type embryos
treated with 10 AMDEAB from 6 to 39 hpf; posterior cranial motor neurons
cannot be unambiguously identified.
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early and late gastrula stages. The development of more
anterior branchiomotor neurons, such as the facial nucleus
(nVII), is insensitive to DEAB treatment at 11 hpf, but is
affected by earlier treatments (see below).
It is conceivable that contribution of Raldh2 mRNA or
protein from the maternal genome may retain residual
signaling activity before shield stage. Therefore, we applied
DEAB at 1.5 hpf (16-cell stage). At concentrations of 5 AM
(not shown) and 10 AM (Fig. 3H), these phenotypes are not
significantly stronger than those of embryos treated at 6 hpf
(Figs. 3H, I; Table 1). Embryos incubated similarly in 20
AM DEAB develop aberrantly and die before 39 hpf,
indicating that 10 AM treatments achieve a maximum level
of inhibition. These results suggest that RA signaling before
6 hpf has little or no influence on the patterning of
developing cranial motor neurons.
To determine the consequences of reduced RA signaling
in nls, we detected isl-1 expression in nls and in embryos
treated with 10 AM DEAB. Changes in motor neuron pat-
terning observed with isl-1 mirror those seen in the Isl1-GFP
line (Fig. 4). Cranial motor neurons in nls resemble a state of
RA-signaling that is intermediate between the phenotypes
resulting from DEAB treatment commencing during (6 hpf)
and after (11 hpf) gastrulation (Fig. 4C). The relatively mild
reduction in AP extent of the vagal nucleus confirms that
Raldh2 acts during gastrulation stages and implies the pres-
ence of additional sources of RA during gastrulation.
Development of cranial nerve projections in the absence
of RA
To analyze the axonal projection pattern of branchiomo-
tor neurons after inhibition of RA-mediated AP signaling in
more detail, we labeled embryos with antibodies against
zebrafish L1 (zL1) and polysialic acid (PSA). zL1 is
expressed in a spatiotemporal pattern on all axons duringTable 1
Temporal requirement of RA signaling for motor neuron patterning
Concentration of
inhibitor (AM)
Commencement
of inhibition (hpf)
Length of
all sectors
Length of each
areaa (Am)
I + II + III
(Am)
I II III
0 (controls) 0 380 108 100 173
10 1,5 191 65 63 70
10 6 184 76 55 66
10 8 235 87 79 95
10 11 378 86 106 186
20 6 191 75 54 57
20 8 238 80 90 74
20 11 378 89 109 180
a The hindbrain was divided into three areas, roughly corresponding to the
position of the trigeminal nuclei and exit points of the facial nerves (nV-
nVII; sector I), posterior facial and glossopharyngeal nuclei (nVII-nIX;
sector II), and vagal nuclei (nX, sector III). Lengths were averaged for the
sample size (n = 20) and were compared between untreated controls and
RA signaling-inhibited larvae at 39 hpf.development and therefore serves as a pan-axonal marker
(Weiland et al., 1997). Antibodies against PSA, a sugar
epitope on the neural cell adhesion molecule, selectively
label motor axons in cranial nerves V, VII, IX, and X (Marx
et al., 2001).
Ventral views of double labeled control embryos at 48 hpf
reveal the locations of branchiomotor nuclei in the hindbrain
and the typical pathways of cranial nerves in the peripheral
nervous system (PNS) (Fig. 5A). The original stacks of the
confocal images were used to generate a graphical recon-
struction for better discrimination of the various branches
(Fig. 5B). In nls mutants, axons innervating the mandibular
(V) and hyoid (VII) arch are present, but their normal
projection pattern is altered to variable amounts (Figs. 5C,
D). The medial projecting branch of the trigeminal nerve
(Va) is missing in 50% of nls embryos, whereas the two
anterior projecting branches (Vb, Vc) are not affected (Fig.
5D). In DEAB-treated embryos, the nuclear region of nVII is
enlarged (measuring an averaged 29 Am, against 20 Am in
nls) and appears to be located more dorsally within the
hindbrain. In addition, one facial nerve branch (VIIa) is
missing in about 80% of the investigated embryos (N = 40),
while the other facial nerve branches (VIIb, VIIc) appear
normal. The nuclei of cranial nerves IX and X are reduced in
size and only a few, short PSA-positive vagal and glosso-
pharyngeal axons exit the hindbrain (Figs. 5C, D).
DEAB-treated embryos exhibit more severe defects
(Figs. 5E, F). In all investigated embryos (N = 50), the
vagal nucleus (nX) is reduced to variable amounts and vagal
axons are missing entirely. Facial and trigeminal nuclei are
Fig. 5. Projection pattern of cranial nerves in neckless and DEAB-treated
embryos. Projections of confocal images of 48 hpf embryo wholemounts
stained with antibodies against zL1 (green) and PSA (red). (A) In control
embryos, zL1 is expressed on all axons, whereas PSA selectively labels
motor axons in cranial nerves V, VII, IX, and X. (B) Schematic drawing
derived from the original stack shown in A, illustrating the nuclei and
pathways of cranial nerves in color coding. In nls mutants (C, D), the
nucleus of cranial nerve X (nX) is reduced in size and only a few, short
PSA-positive vagal axons (X) leave the hindbrain. The facial nucleus (nVII)
is enlarged and one facial nerve branch (VIIa) is missing. The other facial
nerve branches (VIIb, VIIc) appear normal. The medial-projecting branch
of the trigeminal nerve (Va) is missing in 50% of nls embryos (D), whereas
the two anterior projecting branches (Vb, Vc) are not affected. In DEAB-
treated embryos (E, F), the vagal nucleus (nX) is reduced to variable
amounts and vagal axons (X) are either missing (F) or rudimentary present
(E). The facial nucleus (nVII) is either enlarged in size (E) or fused with
other PSA-positive neurons to a single structure (asterisk in F). Ventral (A–
D) and dorsal (E, F) views, anterior is to the top. Scale bars: 50 Am.
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glossopharyngeal nerve is always absent. Consistent with
our observed effects on pre-rhombomeric gene expression,
the stronger phenotypes in all posterior motor domains
suggest that DEAB reduces RA signaling more severely
than in nls. Interestingly, we noted that the staining of PSA
appears to be more intense in nls and DEAB-treatedembryos as compared to controls. This might indicate a
regulatory function of retinoic acid on the amount of PSA
expression during development.
To analyze whether other axon projection patterns are also
affected by inhibition of RA signaling, we labeled embryos
with an antibody against TAG-1. In the zebrafish PNS, TAG-
1 is expressed by cell bodies and axons of motor neurons in
the spinal cord, dorsal root ganglion cell bodies and their
axons, and the lateral line nerves (Ott et al., 2001). In control
embryos, motor nerves from the first three spinal cord
segments first project distally onto the yolk and then turn
rostral (Fig. 6A). Although these motor nerves are present in
nls mutants and their growth pattern is not affected, they are
shorter (Fig. 6B). Following DEAB-treatment, the motor
nerve from the first segment is absent in about 10% of the
embryos (Fig. 6C). In addition, the growth pattern of the first
three motor nerves on the yolk is altered. Branching of these
nerves is reduced and instead of turning rostral the nerves
project further distally. Growth patterns of motor axons
caudal to the third spinal segment are not affected in nls
mutants or after DEAB treatment (not shown). This suggests
that RA signaling is not involved in motor neuron induction
in the spinal cord, but is required for the establishment of
growth patterns of the first three spinal motor nerves.
Sensitivity of lateral line nerve projections to RA signaling
We also noted that inhibition of RA signaling interferes
with the development of the lateral line nerves. At 48 hpf,
the anterior and posterior lateral line nerves are well
developed in control embryos (Figs. 7A, B) and axons of
the posterior nerve have reached the last myotome (not
shown). In nls mutants, the anterior lateral line nerve is
present and its growth pattern is indistinguishable from that
seen in controls. However, the posterior lateral line nerve is
always markedly reduced in diameter (Fig. 7C) and fails to
grow beyond the first myotome in about 30% of mutants
(Fig. 7D). In addition, the ganglion of the posterior lateral
line nerve is always reduced in size (Figs. 7C, D). In DEAB-
treated embryos, the anterior lateral line nerve is again not
affected (Fig. 7E). In contrast, the posterior lateral line nerve
develops only rudimentary stumps in all embryos (Figs. 7E,
F). The ganglion of the posterior lateral line nerve is
particularly reduced in size and often fused with remnants
of other sensory ganglia (Figs. 7E, F). These findings further
point toward a role of RA-mediated AP signaling in the
development of the posterior lateral line system.Discussion
Raldh2 and additional sources of RA contribute to neural
AP patterning
We have studied the effects of inhibiting RA signaling on
hindbrain segmentation and subsequent neuronal patterning
Fig. 6. Projection pattern of motor neurons in neckless and DEAB-treated embryos. Projections of confocal images of 48 hpf embryo wholemounts stained with
an antiserum against zfTag-1, which is expressed by motor axons in the spinal cord. In control embryos, motor nerves from the first three spinal cord segments
first project distally onto the yolk and then turn rostral (A, 1–3). In nls these three motor nerves are present, but they appear to be shorter (B, 1–3). After
DEAB-treatment, the motor nerve from the first segment is missing in about 10% of the embryos (C, dotted line) and the growth pattern of the first three motor
nerves on the yolk is less branched and directed distally. Dorsal views, anterior is to the top. Oto: otholith. Scale bars: 100 Am.
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VAD in birds and rats (Gale et al., 1999; Maden et al., 1996;
White et al., 2000), interference with RA receptor activities
in frog and mouse (Dupe´ et al., 1999; van der Wees et al.,
1998; Wendling et al., 2001), and the Raldh2/ mouse
(Niederreither et al., 2000), the segmental organization and
gene expression of the RA-deficient hindbrain in nls zebra-
fish resembles a state of reduced, but not completely
inhibited, RA signaling activity.
BMS493 inhibits the activation of all three RA-receptor
(RAR) subforms in amniotes (Dupe´ and Lumsden, 2001;
Wendling et al., 2000) and is thought to act by reinforcing
co-repressor binding to RAR; moreover, antagonist binding
enhances the silencing effect of unliganded retinoid receptor
complexes (RAR/RXR) bound to retinoic acid response
elements (Germain et al., 2002). Application of BMS493Fig. 7. The posterior lateral line nerve is affected in neckless and in DEAB-treated e
C, E: overviews; B, D, F: higher magnifications of the posterior lateral line system
expressed by ganglia and axons of the lateral line nerves. In control embryos (A, B
In nls mutants (C, D), the aln is present, however, the pln is always remarkably re
asterisk). In addition, the ganglion of the posterior lateral line nerve (plg) is alwa
affected (E) but the pln develops only rudimentary stumps (E, F). The plg is remark
(E, F). Lateral views, anterior is to the left. Scale bars: 100 Am (A, C, E) and 50to zebrafish embryos leads to almost exact phenocopies of
nls in the posterior hindbrain (Fig. 2C) (Grandel et al.,
2002). Although this reinforces the notion that nls mutants
are devoid of RA signaling from nls/raldh2, it is possible
that BMS493 may not efficiently inhibit all RAR-mediated
signaling in zebrafish. Thus, alternative agents, which
inhibit RA signaling, may be required to investigate the
full extent of RA function during neural patterning in
zebrafish. Citral, a competitive inhibitor of the aldehyde
dehydrogenase-mediated oxidation of retinol and retinal to
RA (Chen et al., 1995; Connor and Smit, 1987; Kikonyogo
et al., 1999) and disulfiram, which inhibits the activity of
aldehyde dehydrogenase class 1 enzymes (Vallari and Pie-
truszko, 1982; Veverka et al., 1997), are likely to display a
comparatively wide substrate specificity. Therefore, we
applied DEAB to block RA synthesis. DEAB is a compet-mbryos. Projections of confocal images of 48 hpf embryo wholemounts (A,
in different embryos) stained with an antiserum against zTAG-1, which is
), the anterior (aln) and posterior (pln) lateral line nerves are well developed.
duced in diameter (C) and often fails to grow beyond the first myotome (D,
ys reduced in size (C, D). In DEAB-treated embryos (E, F), the aln is not
ably reduced in size and often fused with remnants of other sensory ganglia
Am (B, D, F).
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retinaldehyde dehydrogenases, but not on Aldh2 or Aldh3
(Russo et al., 1988, 2002). Furthermore, inhibition of RA
synthesis with DEAB in a zebrafish transgenic reporter line
(RGYn2), in which yellow fluorescent protein is under the
control of RA-response elements, leads to loss of reporter
activation in tissues that exhibit mutant phenotypes in nls
(Perz-Edwards et al., 2001), suggesting that DEAB strongly
inhibits Raldh2 activity in embryonic zebrafish.
Our analysis shows that DEAB treatment affects AP
patterning of the neural tube in a similar fashion as seen in
full VAD in amniotes. The neural tube is strongly ante-
riorized, and the expansion of the hindbrain posterior to r5
is prevented. Some of the other developmental defects in
nls, including absence of forelimbs and reduction of
branchial arches, are stronger or as strong as in full
VAD or in the Raldh2/ mouse. It is therefore likely that
nls embryos retain levels of RA signaling, particularly in
the posterior neural tube, which suffice for proper neural
patterning. One formal possibility for this could be a
maternal supply of RA itself in nls embryos. Alternatively,
the presence of other retinaldehyde dehydrogenases may
compensate for a complete loss of RA signaling. A survey
of all zebrafish nucleotide entries in GenBank (540000
sequences; October 2003) for the three members of the
retinaldehyde dehydrogenase subfamily (Aldh1a1, -a2, -a3)
currently identifies only Raldh2 (Aldh1a2). Our attempts to
clone the remaining Raldhs by RT-PCR using degenerate
primers so far were unsuccessful and genomic scaffolds of
the zebrafish genome presently contain parts of the raldh2
locus only (Ensembl contig: ctg12959). Nevertheless, since
the puffer fish genome appears to contain orthologs of all
three Raldhs (encoded on scaffolds FM_M001420,
FM_M000233, FM_M004033), the identification of ortho-
logs of the remaining enzymes in zebrafish can be
expected soon.
Interestingly, in Raldh2/ mutant mouse embryos, an
RA-producing activity in the ventral hindbrain during the
establishment of rhombomeric boundaries has been in-
ferred from the activation of a RA reporter in condition-
ally rescued mutants (Mic et al., 2002; Niederreither et al.,
2002). None of the known Raldhs are expressed in this
region, suggesting the existence of an as yet uncharacter-
ized enzymatic activity that provides RA to the posterior
hindbrain and anterior spinal cord. The presence of almost
normal hindbrain segmentation in nls mutant zebrafish
suggests that such an activity is present in zebrafish,
where it acts in parallel to Raldh2 and partially comple-
ments its function. In contrast to the mouse, this implies
that at least two independent RA-producing activities have
to be involved in neural patterning along the anteroposte-
rior axis. It will therefore be interesting to identify
additional sources of RA and then to investigate whether
in fish there is partial redundancy between two synthetic
pathways and whether the synthetic proteins are expressed
in non-overlapping domains.Formation of cranial motor neurons in anteriorized neural
tubes
A decrease in the level of RA signaling anteriorizes the
neural plate, such that rhombomere boundaries are shifted
posteriorly, concomitant with a loss of rhombomeric gene
expression in the more posterior regions of the hindbrain.
A detailed description of the development of cranial motor
nuclei under reduced RA signaling has been missing so
far. We have therefore analyzed the relative positions of
cranial motor neuron cell bodies and used them as land-
marks to determine the effects on AP patterning in DEAB-
treated embryos. Motor neuron cell bodies were visualized
in a transgenic zebrafish line expressing GFP under the
control of the islet-1 promoter. To study the projection
patterns of specific axonal populations, we used several
antibodies against axonal cell surface components. These
antibodies either served as pan-axonal markers (zL1) or
selectively label well-defined subpopulations of axons
including motor axons (PSA) and the lateral line nerves
(TAG-1).
By analyzing the effects of commencing inhibition of RA
signaling at various time points, we find that inhibition of
RA synthesis after 11 hpf leads to a substantial reduction in
the number of vagal (X) neurons. Thus, after the end of
gastrulation AP patterning of hindbrain motor neurons is
largely independent of RA signaling and implies a further
role for RA in promoting proliferation or differentiation of
cranial motor neurons.
As expected from the early changes in AP patterning
derived from gene expression studies (Begemann et al.,
2001; Grandel et al., 2002), a reduction of levels of RA
synthesis during gastrulation shortens the posterior extent
of the hindbrain, characterized by vagal nuclei and their
axons, in a time- and concentration-dependent manner.
Alterations in RA signaling during gastrula stages, when
hindbrain rhombomeres are patterned, have much more
profound effects on the position of posterior rhombomere
boundaries than on anterior ones. Consequently, we find
that disrupting RA signaling during this period largely
affects the development of posterior cranial nerves (VII
and X). AP patterning of motor neurons in the midbrain
(III) and anterior hindbrain (V) is not altered. Because the
nuclei of cranial nerve V originate in rhombomeres r2 and
r3, we conclude that RA does not influence neuronal
development anterior to r3.
Interestingly, when RA signaling is decreased, the ante-
rior-most area of the hindbrain, which in our analysis
includes the branchiomotor nuclei of the trigeminal (V)
and facial (VII) nerves, is reduced in length (Fig. 3I). This
seems surprising, as segmental gene expression domains
that precede this area at neurula stages are expanded
posteriorly. Even though inhibition of RA before the tailbud
stage posteriorizes the neural tube, resulting in enlarged
rhombomeres that contain more cells of the same segmental
fate, the corresponding areas at 39 hpf are shorter than in
G. Begemann et al. / Developmental Biology 271 (2004) 119–129128wild type embryos. Moreover, we find that brains of nls and
DEAB-treated embryos, compared to wild type, are consis-
tently enlarged along the medio-lateral axis (Figs. 3, 4).
Together, this indicates that RA signaling appears to be
involved in the regulation of cell movements that underlie
morphogenesis of the larval brain. In support of this,
BMS493 or DEAB treatments after the tailbud stage
(Grandel et al., 2002, and not shown) do not posteriorize
the neural tube, yet territories of anterior rhombomeres are
still shortened when antagonist is applied between 11 and 39
hpf (Figs. 3B, E, I).
Why do posterior cranial motor neurons develop at all in
RA-deficient brains?
Probably most surprisingly, our data suggest that bran-
chiomotor neurons in the posterior hindbrain (VII, X)
develop to some extent, despite the absence of rhombo-
meric patterning posterior to r5. Although in zebrafish the
facial (VII) neurons are in r6 and r7, the developmental
expression of neuronal markers suggests that facial neu-
rons originate in an area encompassing r4 to r6 early in
development and finally come to be positioned in r6 and
r7 (summarized in Chandrasekhar et al., 1997). Similarly,
a caudally directed migration of nVII neurons is thought to
establish the adult pattern of branchiomotor nuclei in
sharks and in many other vertebrates (Chandrasekhar et
al., 1997; Gilland and Baker, 1993, and references there-
in). The presence of facial nuclei even in the most
rigorously RA signaling inhibited hindbrains could there-
fore be a result of their caudal migration into an area
mispatterned through anteriorization. Our results imply
that such a caudal migration is independent of RA
signaling. This explanation may similarly account for the
presence of nVII cranial ganglia in Raldh2/ mice. In the
mouse, nVII nuclei are in r4 and r5, with a few in r6
(Carpenter et al., 1993). Their presence in Raldh2/
knockouts, where segmentation is aberrant in r4 and is
undetectable in an area spanning r5 to r8 (Niederreither et
al., 2000), was therefore unexpected. Neuronal migration
of nVII neurons caudally from r4 into r5 and r6 in the
mouse has been suggested (Fritzsch, 1996; Goddard et al.,
1996; Studer et al., 1996), however, early migration of
nVII neurons in either fish or amniotes awaits direct
demonstration.
Vagal (X) neurons are most severely affected in RA
signaling deficient embryos. The branchiomotor nuclei of
the vagal nerves are in the caudal hindbrain, posterior to r7,
an area that is differently organized than the remaining
hindbrain and superficially unsegmented. Even at the high-
est antagonist concentrations, applied from the 16-cell stage
onwards, a few vagal nerves always appear to develop (Figs.
3H, 4F). Their origin is unknown and they may remain
either due to inefficient RA signaling inhibition, or path-
ways other than RA signaling may be involved in patterning
the hindbrain–spinal cord junction.Acknowledgments
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